Getagraph.com logo
S&P 500
(0.68%) 5 052.71 points
Dow Jones
(0.65%) 38 151 points
Nasdaq
(1.16%) 15 786 points
Oil
(-0.08%) $78.94
Gas
(5.28%) $2.03
Gold
(-0.02%) $2 310.60
Silver
(0.49%) $26.88
Platinum
(1.09%) $965.30
USD/EUR
(0.02%) $0.933
USD/NOK
(-0.23%) $11.00
USD/GBP
(0.04%) $0.799
USD/RUB
(-1.35%) $92.00

Realaus laiko atnaujinimai NextCure Inc [NXTC]

Birža: NASDAQ Sektorius: Healthcare Pramonė: Biotechnology
Upcoming Earnings Alert

Quarter results today
(bmo 2024-05-02)

Expected move: +/- 8.19%

Atnaujinta2 geg. 2024 @ 20:42
25% discount on Stockinvest.us - Use code: Podcast

10.22% $ 1.510

Live Chart Being Loaded With Signals

Commentary (2 geg. 2024 @ 20:42):

NextCure, Inc., a clinical-stage biopharmaceutical company, engages in discovering and developing novel immunomedicines to treat cancer and other immune-related diseases by restoring normal immune function...

Stats
Šios dienos apimtis 59 362.00
Vidutinė apimtis 303 626
Rinkos kapitalizacija 42.24M
EPS $0 ( 2024-03-21 )
Kita pelno data ( $-0.460 ) 2024-06-20
Last Dividend $0 ( N/A )
Next Dividend $0 ( N/A )
P/E -0.670
ATR14 $0.0150 (0.99%)
Insider Trading
Date Person Action Amount type
2024-03-29 Shaw Kevin G. Buy 93 900 Employee Stock Option (Right to Buy)
2024-03-29 Richman Michael Buy 244 400 Employee Stock Option (Right to Buy)
2024-03-29 Myint Han Buy 93 900 Employee Stock Option (Right to Buy)
2024-03-29 Mayer Timothy Buy 93 900 Employee Stock Option (Right to Buy)
2024-03-29 Langermann Sol Buy 93 900 Employee Stock Option (Right to Buy)
INSIDER POWER
100.00
Last 94 transactions
Buy: 6 167 538 | Sell: 82 463

Tūris Koreliacija

Ilgas: 0.05 (neutral)
Trumpas: -0.50 (neutral)
Signal:(49.149) Neutral

NextCure Inc Koreliacija

10 Labiausiai teigiamai susiję koreliacijos
10 Labiausiai neigiamai susiję koreliacijos

Ar žinojote?

Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).

Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.

NextCure Inc Koreliacija - Valiuta/Žaliavos

The country flag 0.70
( moderate )
The country flag 0.65
( weak )
The country flag 0.00
( neutral )
The country flag 0.07
( neutral )
The country flag -0.73
( moderate negative )
The country flag -0.84
( strong negative )

NextCure Inc Finansinės ataskaitos

Annual 2023
Pajamos: $0
Bruto pelnas: $-3.68M (0.00 %)
EPS: $-2.25
FY 2023
Pajamos: $0
Bruto pelnas: $-3.68M (0.00 %)
EPS: $-2.25
FY 2022
Pajamos: $0
Bruto pelnas: $-4.48M (0.00 %)
EPS: $-2.50
FY 2021
Pajamos: $0.00
Bruto pelnas: $0.00 (0.00 %)
EPS: $-2.51

Financial Reports:

No articles found.

NextCure Inc

NextCure, Inc., a clinical-stage biopharmaceutical company, engages in discovering and developing novel immunomedicines to treat cancer and other immune-related diseases by restoring normal immune function. Its lead product candidate is NC318, which is in Phase II clinical trials for the treatment of advanced or metastatic solid tumors. The company is also developing NC410, which is in Phase I for novel immunomedicine designed to block immune suppression mediated by an immune modulator called Leukocyte-Associated Immunoglobulin-like Receptor 1; NC762, an immunomedicine targeting a molecule called human B7 homolog 4 protein, or B7-H4; and NC525, a novel LAIR-1 antibody which is in Preclinical trails that targets acute myeloid leukemia, blast cells, and leukemic stem cells. Its discovery and research programs include an antibody in preclinical evaluation of other potential novel immunomodulatory molecules. The company has a license agreement with Yale University. NextCure, Inc. was incorporated in 2015 and is headquartered in Beltsville, Maryland.

Apie Signalai gyvai

Šiame puslapyje pateikti tiesioginiai signalai padeda nustatyti, kada PIRKTI ar PARDUOTI NA. Signalai vėluoja 1 minutę; kaip ir su visais rinkos signalais, taip ir su šiais, visuomet yra klaidų tikimybė.

Tiesioginiai prekybos signalai nėra apibrėžti, todėl getagraph.com neprisiima atsakomybės už jokius veiksmus, kurių buvo imtasi žinant šiuos signalus, kaip aprašyta Naudojimo sąlygose. Signalai yra pagrįsti įvairiais techninės analizės rodikliais.